The ChemRar Group of Companies and the national distributor of medicines in Colombia, Pharmaceutical Health Corporation S.A.S, signed an agreement on the supply of medicines. The list of drugs that ChemRar will supply to the Latin American country includes Temozolomide (temozolomide), Lantoger (gefetinib), Sunitinib-Chimrar (sunitinib), Potarbin (pazopanib) and Lapatinib-Chimrar ( lapatinib).
In Latin America, the Russian manufacturer already has projects in Brazil, Mexico, Argentina, Chile, Guatemala, and Costa Rica. “The signing of another contract, this time with a Colombian company, indicates the demand for Russian pharmaceutical products in non-CIS countries,” said Irina Tyrnova, a member of the board of directors of ChemRar Group of Companies, General Director of the Kromis company.
According to WHO, about 9 million people die from cancer every year. More than 14 million new cases of cancer are diagnosed every year. At the same time, in Colombia, deaths from various types of cancer reached 22.13% of the total mortality rate.
